Article Listing - Isis earns $25 million milestone from Genzyme as US FDA accepts Kynamro NDA

SMITHKLINE BEECHAM PROMOTIONS

10 February 1992

SmithKline Beecham has announced the appointment of Richard Torrenzano as director and senior vice president for corporate affairs.

ROCHE PROMOTIONS

10 February 1992

Claude Schreiner has been named as president of Produits Roche and Societe Chimique Roche.

NOVOPHARM APPOINTMENT

10 February 1992

Novopharm Ltd of Canada has announced the appointment of Audrey Bloyard to the newly-created position of vice president, marketing.

US HEALTH CARE ISSUES IN BUSH SPEECH TO NATION

10 February 1992

President Bush's proposal in his State of the Union message to make the 20% tax credit on incremental R&D spending...

NEW CHEMICAL ENTITIES UPDATE FOR 1991

10 February 1992

1991 was an interesting year in terms of New Chemical Entities, with a number of products of blockbuster potential coming...

IMPEDIMENTS TO EC PARALLEL PHARMA TRADE

10 February 1992

Within the European Community there are a number of impediments to parallel trade in prescription medicines, according to a study...

EARNINGS DOUBLE AT R-P RORER

10 February 1992

Franco-American pharmaceutical concern Rhone-Poulenc Rorer reported last week that its net income for 1991 had doubled, compared with 1990 figures...

SHARP EARNINGS DROP FOR SOLVAY

10 February 1992

Belgium's largest chemical and pharmaceutical concern Solvay experienced a sharp fall in net earnings in 1991, which was marked by...

US HOSPITALS FEAR DISCOUNT "DISASTER"

10 February 1992

An average hospital in the USA could have to pay $389,000 more each year, or an increase of 23.4%, to...

RECORD 4TH QTR FROM US DRUG COMPANIES

10 February 1992

The current batch of US financial results includes record 1991 results from Johnson & Johnson and Marion Merrell Dow, and...

Showing 94841-94850 of 95376 articles

Go to beginningPreviousNextGo to end